Thread by @WHO

Resistant bacterial infections cause nearly 5 million deaths every year.

#VaccinesWork to reduce the use & overuse of antibiotics, which are 🔑 drivers of #AntimicrobialResistance.

🆕 report describes all vaccines currently in development for priority bacterial pathogens ⬇️

#AntimicrobialResistance (AMR) occurs when:
🔸 bacteria
🔸 viruses
🔸 fungi
🔸 parasites
no longer respond to medicines, ↗️ the risk of disease spread, severe illness & death.

🆕 vaccines in development have the potential to impact AMR & save lives:
📌 bit.ly/3uH3Xic

Vaccines are highly effective tools in combating #AntimicrobialResistance by:
🎯 directly targeting resistant bacteria
🩹 reducing the incidence of both resistant & susceptible infections, thereby ⬇️ #antibiotic consumption, which is a 🔑 driver of AMR

📌 bit.ly/3uH3Xic

The analysis identifies 6⃣1⃣ vaccine candidates in various stages of clinical development, incl. several vaccine candidates against priority pathogens that are in late stages of development. Most of these vaccines will not be available anytime soon

📌 bit.ly/3uH3Xic

The 🆕 report stresses that access to these vaccines should be increased globally, especially among populations that need them most in limited resource settings.

📌 bit.ly/3uH3Xic

The first WHO analysis providing data for the 🌐 R&D community to guide investments & research into feasible vaccines to mitigate #AntimicrobialResistance highlights that for the most critical gram-negative bacteria, the vaccine pipeline is weak.

https://twitter.com/WHO/status/1546897790760017922?s=20&t=Dog97wkzB3XqeGK5GDgVag